<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04138797</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2019/11</org_study_id>
    <nct_id>NCT04138797</nct_id>
  </id_info>
  <brief_title>Evaluation of Non-invasive Measurement of Electrophysiological &quot;HV&quot; Interval Using a High-density and High-fidelity Signal Averaging ECG Device</brief_title>
  <acronym>BIOSEMI-HV</acronym>
  <official_title>Evaluation of Non-invasive Measurement of Electrophysiological &quot;HV&quot; Interval Using a High-density and High-fidelity Signal Averaging ECG Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      His-Ventricle (HV) measurement is only obtained invasively using transvenous catheters. This
      kind of procedure is routinely performed but some risks of complication exist. HV interval
      prolongation is correlated with increased risk of occurrence of complete atrioventricular
      block which could lead to syncope or cardiac sudden death. A new non invasive, high density
      and high fidelity system (BioSemi, BioSemi B.V., Amsterdam, Netherlands) can theorically
      collect such electrophysiological signal using a signal averaging acquisition method. We want
      to assess the possibility of non invasive HV interval measurement using this new device.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 7, 2019</start_date>
  <completion_date type="Anticipated">October 8, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of HV interval correlation by the intra-class correlation coefficient</measure>
    <time_frame>Day 0</time_frame>
    <description>The correlation of the HV interval obtained using the 2 different methods, is measured by a correlation coefficient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of HV interval correlation by graphical representation</measure>
    <time_frame>Day 0</time_frame>
    <description>The correlation of the HV interval obtained using the 2 different methods, is measured by a graphical representation of Bland and Altman</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cardiac Electrophysiology</condition>
  <condition>Electrocardiogram</condition>
  <arm_group>
    <arm_group_label>Electrophysiological exploration &amp; ECG Biosemi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrophysiological exploration</intervention_name>
    <description>Electrophysiological exploration is performed, as part of the routine care, after the Biosemi high density ECG, the same day or maximum 4 days later. It is performed in interventional rhythmology room, under fluoroscopic control. After local anesthesia, one or more introducers are placed in the femoral vein allowing the introduction of catheters. These catheters allow recording of the HV interval</description>
    <arm_group_label>Electrophysiological exploration &amp; ECG Biosemi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ECG Biosemi</intervention_name>
    <description>Non invasive ECG monitoring for HV measurement using high density Biosemi device. This device use 256 skin electrodes. At the same time and with the same system, a chest pressure sensor can record the patient's breathing movements.</description>
    <arm_group_label>Electrophysiological exploration &amp; ECG Biosemi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients admitted at Bordeaux University Hospital for electrophysiological study with
             HV measurement.

        Exclusion Criteria:

          -  Patients under 18 years old,

          -  Pregnant or breastfeeding women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josselin DUCHATEAU, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Josselin DUCHATEAU, MD</last_name>
    <phone>(0)5 57 65 64 01</phone>
    <phone_ext>+33</phone_ext>
    <email>josselin.duchateau@chu-bordeaux.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carine LOPEZ</last_name>
    <phone>(0)5 24 54 91 17</phone>
    <phone_ext>+33</phone_ext>
    <email>carine.lopez@chu-bordeaux.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bordeaux University Hospital</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josselin DUCHATEAU, MD</last_name>
      <phone>(0)5 57 65 64 01</phone>
      <phone_ext>+33</phone_ext>
      <email>josselin.duchateau@chu-bordeaux.fr</email>
    </contact>
    <contact_backup>
      <last_name>Carine LOPEZ</last_name>
      <phone>(0)5 24 54 91 17</phone>
      <phone_ext>+33</phone_ext>
      <email>carine.lopez@chu-bordeaux.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Josselin DUCHATEAU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frédéric SACHER, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romain TIXIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>October 24, 2019</last_update_submitted>
  <last_update_submitted_qc>October 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Signal Averaging ECG</keyword>
  <keyword>HV interval</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

